(NYSE MKT: NBS) NeoStem: RedChip Money Report Interview – Fox Business – Video

Posted: February 2, 2013 at 7:41 pm




(NYSE MKT: NBS) NeoStem: RedChip Money Report Interview - Fox Business
Dave Gentry interviews Dr. Robin Smith, Chairman CEO of NeoStem (NYSE MKT: NBS), a biopharmaceutical company capitalizing on the paradigm shift occurring in medicine by developing and manufacturing stem cell therapies. During the interview, Dr. Smith discusses NeoStem #39;s current pipeline, including AMR-001, the company #39;s Phase 2 stem cell therapy for acute myocardial infarction. Dr. Smith also discusses her upcoming book on adult stem cells, "The Healing Cell," due for release in April 2013. The book was co-authored by the Vatican #39;s Pontifical Council for Culture and includes a foreword by Pope Benedict XVI. "The RedChip Money Report" trade; delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies. The show is hosted by Dave Gentry, a leading authority on small-cap stocks and president of RedChip, an international small-cap research firm and an Inc. 5000 company. Mr. Gentry has made multiple guest appearances on both CNBC and Fox Business News and has been a consultant to hundreds of public companies. "The RedChip Money Report" trade; airs Saturdays at 2:30 pm on Fox Business News, a premium business network reaching more than 65 million homes nationwide. The weekly program also airs on My Family TV and TUFF TV.

By: RedChip Money Report Gentry

More here:
(NYSE MKT: NBS) NeoStem: RedChip Money Report Interview - Fox Business - Video

Related Posts